126 related articles for article (PubMed ID: 10594540)
41. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid.
Corrigan CJ; Kettner J; Doemer C; Cromwell O; Narkus A;
Allergy; 2005 Jun; 60(6):801-7. PubMed ID: 15876311
[TBL] [Abstract][Full Text] [Related]
42. The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy.
Benjaponpitak S; Oro A; Maguire P; Marinkovich V; DeKruyff RH; Umetsu DT
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):468-75. PubMed ID: 10069882
[TBL] [Abstract][Full Text] [Related]
43. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
Asero R
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
[TBL] [Abstract][Full Text] [Related]
44. Responses of human birch pollen allergen-reactive T cells to chemically modified allergens (allergoids).
Dormann D; Ebner C; Jarman ER; Montermann E; Kraft D; Reske-Kunz AB
Clin Exp Allergy; 1998 Nov; 28(11):1374-83. PubMed ID: 9824410
[TBL] [Abstract][Full Text] [Related]
45. In vitro allergen-induced mRNA expression of signaling lymphocytic activation molecule by PBMC of patients with allergic rhinitis is increased during specific pollen immunotherapy.
Laaksonen K; Junikka M; Lahesmaa R; Terho EO; Savolainen J
J Allergy Clin Immunol; 2003 Dec; 112(6):1171-7. PubMed ID: 14657878
[TBL] [Abstract][Full Text] [Related]
46. Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy.
Asero R; Mistrello G; Amato S
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):180-5. PubMed ID: 27238577
[TBL] [Abstract][Full Text] [Related]
47. The pattern of human late-phase skin reactions to extracts of aeroallergens.
Frew AJ; Kay AB
J Allergy Clin Immunol; 1988 Jun; 81(6):1117-21. PubMed ID: 3379223
[TBL] [Abstract][Full Text] [Related]
48. Specific IgE response before and after rush immunotherapy with a standardized allergen or allergoid in grass pollen allergy.
Bousquet J; Braquemond P; Feinberg J; Guerin B; Maasch H; Michel FB
Ann Allergy; 1986 Jun; 56(6):456-9. PubMed ID: 3717711
[TBL] [Abstract][Full Text] [Related]
49. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.
Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
J Allergy Clin Immunol; 1996 Jun; 97(6):1356-65. PubMed ID: 8648033
[TBL] [Abstract][Full Text] [Related]
50. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
[TBL] [Abstract][Full Text] [Related]
51. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.
Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M
Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570
[TBL] [Abstract][Full Text] [Related]
52. Date palm pollen allergoid: characterization of its chemical-physical and immunological properties.
Mistrello G; Harfi H; Roncarolo D; Kwaasi A; Zanoni D; Falagiani P; Panzani R
Int Arch Allergy Immunol; 2008; 145(3):224-30. PubMed ID: 17914274
[TBL] [Abstract][Full Text] [Related]
53. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
Hansen I; Hörmann K; Stuck BA; Schneider-Gêne S; Mösges R; Klimek L
Laryngorhinootologie; 2003 Aug; 82(8):558-63. PubMed ID: 12915987
[TBL] [Abstract][Full Text] [Related]
54. Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1alpha.
Gaga M; Ong YE; Benyahia F; Aizen M; Barkans J; Kay AB
Allergy; 2008 Jun; 63(6):703-11. PubMed ID: 18070228
[TBL] [Abstract][Full Text] [Related]
55. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects.
Ying S; Meng Q; Barata LT; Robinson DS; Durham SR; Kay AB
J Immunol; 1997 May; 158(10):5050-7. PubMed ID: 9144526
[TBL] [Abstract][Full Text] [Related]
56. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial.
Caffarelli C; Sensi LG; Marcucci F; Cavagni G
Allergy; 2000 Dec; 55(12):1142-7. PubMed ID: 11117271
[TBL] [Abstract][Full Text] [Related]
57. Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals.
Tsicopoulos A; Hamid Q; Haczku A; Jacobson MR; Durham SR; North J; Barkans J; Corrigan CJ; Meng Q; Moqbel R
J Allergy Clin Immunol; 1994 Oct; 94(4):764-72. PubMed ID: 7930311
[TBL] [Abstract][Full Text] [Related]
58. Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: effects of cetirizine.
Zweiman B; Atkins PC; Moskovitz A; von Allmen C; Ciliberti M; Grossman S
J Allergy Clin Immunol; 1997 Sep; 100(3):341-7. PubMed ID: 9314346
[TBL] [Abstract][Full Text] [Related]
59. Comparison of inflammatory events during developing immunoglobulin E-mediated late-phase reactions and delayed-hypersensitivity reactions.
Zweiman B; Moskovitz AR; von Allmen C
Clin Diagn Lab Immunol; 1998 Jul; 5(4):574-7. PubMed ID: 9665969
[TBL] [Abstract][Full Text] [Related]
60. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2006 Nov; 24(47-48):6990-3. PubMed ID: 17011086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
